NAFDAC will give manufacturers incentives to develop paediatric medicines, says DG

Mojisola Adeyeye, director-general (DG) of the National Agency for Food and Drug Administration and Control (NAFDAC), says manufacturers will get incentives to develop paediatric medicines.

Adeyeye spoke in Lagos on Thursday at a press conference organised to outline the agency’s focus for 2025.

She said the agency would focus on five strategic pillars to safeguard the health of Nigerians.

The NAFDAC DG listed the pillars as strong governance and leadership, maternal, newborn, and child health; institutionalisation of best practices; safety and quality of regulated products; and monitoring of the supply chain.

“Reflection on the past seven years has brought into focus the many accomplishments that have been achieved in NAFDAC and so many others to be attained,” she said.

“This realisation has sharpened my focus on how to strategically work towards continued strengthening of the regulatory system as a needed path toward safeguarding the health of the nation.”

She added that NAFDAC will continue to unlock the value chain by strengthening the industry with a focus on access to quality regulated products.

She said strong governance and leadership would ensure that the agency’s workforce stays highly motivated and disciplined, noting that training will remain a premium for staff.

The DG said the agency would pay more attention to the safety and quality of regulated products for maternal, newborn, and child health and nutrition.

She said this would help to prevent postpartum haemorrhage and maternal deaths to drastically reduce child morbidity.

“Great emphasis will be placed on paediatric antimalarials and antibiotics,” she said.

“Manufacturers will be incentivised to develop paediatric medicines and handhelds toward achieving WHO prequalification.”

Adeyeye noted that the agency is “extremely understaffed.”.

“The number of staff that an agency has or should have depends on the population of the country because it is easier to regulate a country with one million than a country with 300 million people,” she said.

“I’m just giving an example based on our population; we are supposed to have nothing less than 10,000 staff; we have about 2,000 right now.

“We burn candles on both ends, overstress ourselves because we have to safeguard the health of Nigerians.

“We are not asking for 10,000 staff now; we are just asking for double or triple what we currently have.”